The role of autologous bone marrow transplantation in advanced neuroblastoma
JJ Shuster
JCO Sep 1 1996: 2413–2414. [PDF]
Needle biopsy in malignant lymphoma
GS Pinkus
JCO Sep 1 1996: 2415–2416. [PDF]
	Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies
	DO Stram, KK Matthay, M O'Leary, CP Reynolds, GM Haase, JB Atkinson, GM Brodeur, and RC Seeger
	JCO Sep 1 1996: 2417–2426. [Abstract] [PDF]
	Role of image-guided core-needle biopsy in the management of patients with lymphoma
	VI Pappa, HK Hussain, RH Reznek, J Whelan, AJ Norton, AM Wilson, S Love, TA Lister, and AZ Rohatiner
	JCO Sep 1 1996: 2427–2430. [Abstract] [PDF]
	Image-guided core-needle biopsy in malignant lymphoma: experience with 100 patients that suggests the technique is reliable
	D Ben-Yehuda, A Polliack, E Okon, Y Sherman, S Fields, P Lebenshart, H Lotan, and E Libson
	JCO Sep 1 1996: 2431–2434. [Abstract] [PDF]
	Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation
	E Salloum, R Doria, W Schubert, D Zelterman, T Holford, KB Roberts, LR Farber, RK Kiehl, J Cardinale, and DL Cooper
	JCO Sep 1 1996: 2435–2443. [Abstract] [PDF]
	Late psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study
	F Joly, M Henry-Amar, P Arveux, O Reman, A Tanguy, AM Peny, P Lebailly, J Mace- Lesec'h, B Vie, JY Genot, A Busson, X Troussard, and M Leporrier
	JCO Sep 1 1996: 2444–2453. [Abstract] [PDF]
	Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry
	CD Williams, AH Goldstone, RM Pearce, T Philip, O Hartmann, P Colombat, G Santini, L Foulard, and NC Gorin
	JCO Sep 1 1996: 2454–2464. [Abstract] [PDF]
	Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation
	JW Sweetenham, R Pearce, G Taghipour, D Blaise, C Gisselbrecht, and AH Goldstone
	JCO Sep 1 1996: 2465–2472. [Abstract] [PDF]
	Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma
	JM Vose, PJ Bierman, JR Anderson, KA Harrison, GV Dalrymple, K Byar, A Kessinger, and JO Armitage
	JCO Sep 1 1996: 2473–2479. [Abstract] [PDF]
	Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone
	M Weiss, P Maslak, E Feldman, E Berman, J Bertino, T Gee, L Megherian, K Seiter, D Scheinberg, and D Golde
	JCO Sep 1 1996: 2480–2485. [Abstract] [PDF]
	Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study
	SH Bernstein, VL Brunetto, FR Davey, D Wurster-Hill, RJ Mayer, RM Stone, CA Schiffer, and CD Bloomfield
	JCO Sep 1 1996: 2486–2494. [Abstract] [PDF]
	Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group
	JL Finlay, S Goldman, MC Wong, M Cairo, J Garvin, C August, BH Cohen, P Stanley, RA Zimmerman, B Bostrom, JR Geyer, RE Harris, J Sanders, AJ Yates, JM Boyett, and RJ Packer
	JCO Sep 1 1996: 2495–2503. [Abstract] [PDF]
	Successful management of low-stage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution
	AE Evans, JH Silber, A Shpilsky, and GJ D'Angio
	JCO Sep 1 1996: 2504–2510. [Abstract] [PDF]
	Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology
	CL Bennett, TJ Smith, JC Weeks, AB Bredt, J Feinglass, JH Fetting, BE Hillner, MR Somerfield, and RJ Winn
	JCO Sep 1 1996: 2511–2520. [Abstract] [PDF]
	Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells
	MR Bishop, JD Jackson, B O'Kane-Murphy, K Schmit-Pokorny, JM Vose, PJ Bierman, PI Warkentin, JO Armitage, L Garrison, and A Kessinger
	JCO Sep 1 1996: 2521–2526. [Abstract] [PDF]
	Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study
	M Flam, M John, TF Pajak, N Petrelli, R Myerson, S Doggett, J Quivey, M Rotman, H Kerman, L Coia, and K Murray
	JCO Sep 1 1996: 2527–2539. [Abstract] [PDF]
	Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer
	GJ Creemers, CJ Gerrits, JH Schellens, AS Planting, ME van der Burg, VM van Beurden, M de Boer-Dennert, M Harteveld, W Loos, I Hudson, G Stoter, and J Verweij
	JCO Sep 1 1996: 2540–2545. [Abstract] [PDF]
	Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease
	E Bajetta, A Di Leo, L Biganzoli, L Mariani, F Cappuzzo, M Di Bartolomeo, N Zilembo, S Artale, E Magnani, L Celio, R Buzzoni, and C Carnaghi
	JCO Sep 1 1996: 2546–2551. [Abstract] [PDF]
	Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group
	PF Conte, J Latreille, L Mauriac, F Calabresi, R Santos, D Campos, J Bonneterre, G Francini, and JM Ford
	JCO Sep 1 1996: 2552–2559. [Abstract] [PDF]
	Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer
	GF von Tempelhoff, M Dietrich, G Hommel, and L Heilmann
	JCO Sep 1 1996: 2560–2568. [Abstract] [PDF]
	Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor
	JL Passos-Coelho, AA Ross, DJ Kahn, TJ Moss, JM Davis, AM Huelskamp, SJ Noga, NE Davidson, and MJ Kennedy
	JCO Sep 1 1996: 2569–2575. [Abstract] [PDF]
	Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinoma [published erratum appears in J Clin Oncol 1996 Dec;14(12):3175]
	JA Sparano, N Robert, P Silverman, H Lazarus, U Malik, U Venkatraj, and C Sarta
	JCO Sep 1 1996: 2576–2583. [Abstract] [PDF]
	Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy
	T Kuukasjarvi, J Kononen, H Helin, K Holli, and J Isola
	JCO Sep 1 1996: 2584–2589. [Abstract] [PDF]
	Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative
	H Gurney
	JCO Sep 1 1996: 2590–2611. [Abstract] [PDF]
	Status of the medical oncology workforce. The American Society of Clinical Oncology
	JCO Sep 1 1996: 2612–2621. [Abstract] [PDF]
Phase I study of suramin administered by intermittent infusion without adaptive control to cancer patients: update of two expanded dose levels near the maximally tolerated dose
K Kobayashi, EE Vokes, NJ Vogelzang, L Janisch, B Soliven, and MJ Ratain
JCO Sep 1 1996: 2622–2623. [PDF]
Data modifications to phase I study of suramin
K Kobayashi, EE Vokes, NJ Vogelzang, and MJ Ratain
JCO Sep 1 1996: 2623–2624. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.